Identification of SRSF9 through pooled shRNA screening links BNIP3 splicing to autophagy and metabolic reprogramming in breast cancer
Journal of Biological Chemistry · 2025
DOI: 10.1016/j.jbc.2025.110482 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025. Verfasst von Anchala Pandey und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Indian Institute of Science Education and Research, Bhopal, Madhya Pradesh, India. Hauptthemen laut MEDLINE: Breast Neoplasms, Serine-Arginine Splicing Factors, Membrane Proteins, Autophagy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science and Engineering Research Board, Ministry of Education, Indian Council of Medical Research.
Abstract (Originalsprache)
Autophagy is a critical catabolic process that maintains cellular homeostasis, yet the role of alternative splicing in regulating hypoxia-induced autophagy remains largely unexplored. Here, through a pooled shRNA screen of RNA-binding proteins (RBPs) in hypoxic breast cancer cells, we identified the splicing factor SRSF9 as a key regulator. We found that SRSF9 expression is significantly reduced under hypoxia, while its restoration diminishes autophagosome formation. SRSF9 directly controls the alternative splicing of BNIP3 by binding to its third exon, generating two functionally distinct isoforms. The full-length isoform, BNIP3-FL, promotes canonical autophagy by interacting with the BCL-2-BECN1 complex. In contrast, the truncated isoform, BNIP3-Δ3, lacks this function and instead promotes a metabolic shift to the Warburg effect. This metabolic reprogramming by BNIP3-Δ3 enhances breast cancer progression, including proliferation and invasion, and confers chemoresistance to paclitaxel. Collectively, our study identifies a previously unreported mechanism where SRSF9 governs the balance between autophagy and the Warburg effect via BNIP3 alternative splicing, thereby establishing a critical link between splicing regulation, metabolic adaptation, and therapeutic resistance in breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, Indian Institute of Science Education and Research, Bhopal, Madhya Pradesh, India.
- Department of Surgical Oncology, Bansal Hospital, Bhopal, Madhya Pradesh, India.
- Department of Biological Sciences, Indian Institute of Science Education and Research, Bhopal, Madhya Pradesh, India. Electronic address: sanjeevs@iiserb.ac.in.
Förderung
- Science and Engineering Research Board
- Ministry of Education
- Indian Council of Medical Research
Zitieren
APA
Pandey, A., Jithin, B., Mutnuru, S. A., Samaiya, A., & Shukla, S. (2025). Identification of SRSF9 through pooled shRNA screening links BNIP3 splicing to autophagy and metabolic reprogramming in breast cancer. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.110482
Vancouver
Pandey A, Jithin B, Mutnuru SA, Samaiya A, Shukla S. Identification of SRSF9 through pooled shRNA screening links BNIP3 splicing to autophagy and metabolic reprogramming in breast cancer. Journal of Biological Chemistry. 2025. doi:10.1016/j.jbc.2025.110482
BibTeX
@article{Pandey2025,
author = {Pandey, Anchala and Jithin, B and Mutnuru, Srinivas Abhishek and Samaiya, Atul and Shukla, Sanjeev},
title = {Identification of SRSF9 through pooled shRNA screening links BNIP3 splicing to autophagy and metabolic reprogramming in breast cancer},
journal = {Journal of Biological Chemistry},
year = {2025},
doi = {10.1016/j.jbc.2025.110482}
}
EUVIMED